Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System

NAActive, not recruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 1, 2022

Study Completion Date

December 31, 2028

Conditions
Mitral Valve Insufficiency
Interventions
DEVICE

Twelve TMVR Implant

Implantation of the Twelve TMVR System -Apical

DEVICE

Medtronic Intrepid™ Transcatheter Transfemoral Mitral Valve Replacement System

Implant of Intrepid valve -Transfemoral

Trial Locations (17)

10016

NYU Langone Medical Center, New York

10029

Mt. Sinai Medical Center, New York

10032

Columbia, New York

17043

UPMC Pinnacle Harrisburg, Wormleysburg

22908

University of Virginia Medical Center, Charlottesville

30309

Piedmont Hospital, Atlanta

49503

Spectrum Health Hospitals, Grand Rapids

53215

Aurora St. Luke's, Milwaukee

55407

Abbott Northwestern Hospital, Minneapolis

60208

Northwestern University, Chicago

77030

Methodist Hospital, Houston

85016

Abrazo Arizon Heart Hospital, Phoenix

97239

Oregon Health Sciences University Hospital, Portland

Unknown

Royal Prince Alfred Hospital, Sydney

Rigshospitalet, Copenhagen

Centre Hospitalier Universitaire, Lille

St. Thomas' Hospital, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Medtronic Cardiovascular

INDUSTRY